We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MYLAN SEEKS IMMEDIATE RESPONSE FROM FDA ON AUTHORIZED GENERICS
MYLAN SEEKS IMMEDIATE RESPONSE FROM FDA ON AUTHORIZED GENERICS
June 30, 2004
Generic firm Mylan Laboratories is urging the FDA to immediately clarify its position on authorized generics — a move that will likely prompt a lawsuit from either the brand or generic industry.